Summit Therapeutics is a leader in antibiotic innovation.
Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
We are currently developing new mechanism antibiotics for C. difficile infection and are using our proprietary Discuva Platform to expand our pipeline.
Location: United States, Massachusetts, Cambridge
Member count: 51-200
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | CARB-X | carb-x.org |
Mentions in press and media 17
| Date | Title | Description | Category | Author | Source |
| 06.12.2022 | Akeso Inc.... | Akeso Inc. to out-license to S... | - | - | en.prnasia... |
| 10.02.2022 | Summit The... | Summit Therapeutics Announces ... | - | - | marketscre... |
| 09.02.2022 | Summit The... | Cambridge, Massachusetts, Feb.... | - | - | marketscre... |
| 26.01.2022 | Summit The... | Summit Therapeutics Announces ... | - | - | marketscre... |
| 25.01.2022 | Summit The... | Cambridge, Massachusetts, Jan.... | - | - | marketscre... |
| 10.01.2022 | Summit The... | Cambridge, Massachusetts, Jan.... | - | - | marketscre... |
| 05.01.2022 | Summit The... | Cambridge, Massachusetts, Jan.... | - | - | marketscre... |
| 21.12.2021 | Summit The... | Summit Therapeutics Announces ... | - | - | marketscre... |
| 20.12.2021 | Summit The... | Cambridge, MA, Dec. 20, 2021 (... | - | - | marketscre... |
| 15.11.2021 | Summit The... | Cambridge, Massachusetts, Nov.... | - | - | marketscre... |
Show more